NextGen Healthcare
- Home ›
- US ›
- Healthcare
NextGen Healthcare, Inc. provides software, services, and analytics solutions to medical and dental group practices in the United States. The last earnings update was 89 days ago. More info.
Add to Portfolio Compare Print
NXGN Share Price and Events
7 Day Returns
1 Year Returns
NXGN Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| NextGen Healthcare (NXGN) | -1.9% | 4% | -4.6% | 26% | 19.1% | 17.1% |
| US Healthcare Services | -0.2% | 4.4% | 11.5% | 26.8% | 57.2% | 57.4% |
| US Market | -0.1% | 3.7% | 10.2% | 7.6% | 38.1% | 46.4% |
1 Year Return vs Industry and Market
- NXGN outperformed the Market in United States of America which returned 7.6% over the past year.
NXGN Value
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current
share
price of
NextGen Healthcare
to its discounted cash flow analysis.value.The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Below are the data sources, inputs and calculation used to determine the intrinsic value for NextGen Healthcare.
| Data Point | Source | Value |
|---|---|---|
| Valuation Model | 2 Stage Free Cash Flow to Equity | |
| Levered Free Cash Flow | Average of 13 Analyst Estimates (S&P Global) | See below |
| Discount Rate (Cost of Equity) | See below | 9.7% |
| Perpetual Growth Rate | 10-Year US Government Bond Rate | 2.7% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
| Data Point | Calculation/ Source | Result |
|---|---|---|
| Risk-Free Rate | 10-Year US Govt Bond Rate | 2.7% |
| Equity Risk Premium | S&P Global | 6% |
| Healthcare Services Unlevered Beta | Simply Wall St/ S&P Global | 1.22 |
| Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 1.221 (1 + (1- 21%) (2.52%)) |
1.164 |
| Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
1.16 |
| Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (1.164 * 5.96%) |
9.67% |
Discounted Cash Flow Calculation for NasdaqGS:NXGN using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for NextGen Healthcare is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.
| Levered FCF (USD, Millions) | Source |
Present Value Discounted (@ 9.67%) |
|
|---|---|---|---|
| 2019 | 33.23 | Analyst x3 | 30.30 |
| 2020 | 51.44 | Analyst x4 | 42.77 |
| 2021 | 58.20 | Analyst x2 | 44.12 |
| 2022 | 73.20 | Analyst x1 | 50.60 |
| 2023 | 87.80 | Analyst x1 | 55.34 |
| 2024 | 99.80 | Analyst x1 | 57.36 |
| 2025 | 109.54 | Est @ 9.76% | 57.40 |
| 2026 | 117.91 | Est @ 7.65% | 56.34 |
| 2027 | 125.19 | Est @ 6.17% | 54.55 |
| 2028 | 131.63 | Est @ 5.14% | 52.29 |
| Present value of next 10 years cash flows | $501.08 | ||
| Calculation | Result | |
|---|---|---|
| Terminal Value |
= FCF2028
× (1 + g) ÷ (Discount Rate – g)
= $131.63 × (1 + 2.73%) ÷ (9.67% – 2.73%) |
$1,948.31 |
| Present Value of Terminal Value |
= Terminal Value ÷ (1 + r)10
= $1,948.31 ÷ (1 + 9.67%)10 |
$774.04 |
| Calculation | Result | |
|---|---|---|
| Total Equity Value |
= Present value of next 10 years cash flows +
Terminal Value
= $501.08 + $774.04 |
$1,275.12 |
| Equity Value per Share (USD) |
= Total value / Shares Outstanding
= $1,275.12 / 64.70 |
$19.71 |
| Calculation | Result | |
|---|---|---|
| Value per share (USD) | From above. | $19.71 |
| Current discount | Discount to share price of
$17.28
= -1 x ($17.28 - $19.71) / $19.71 |
12.3% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
Current Discount
Current Discount Checks
- NextGen Healthcare's share price is below the future cash flow value, but not at a moderate discount (< 20%).
- NextGen Healthcare's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for NextGen Healthcare's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
NextGen Healthcare's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2018-12-31) in USD | $0.15 |
| NasdaqGS:NXGN Share Price ** | NasdaqGS (2019-04-23) in USD | $17.28 |
| United States of America Healthcare Services Industry PE Ratio | Median Figure of 14 Publicly-Listed Healthcare Services Companies | 79.56x |
| United States of America Market PE Ratio | Median Figure of 3,080 Publicly-Listed Companies | 18.03x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of NextGen Healthcare.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = NasdaqGS:NXGN Share Price ÷ EPS (both in USD) = 17.28 ÷ 0.15 |
116.54x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- NextGen Healthcare is overvalued based on earnings compared to the US Healthcare Services industry average.
- NextGen Healthcare is overvalued based on earnings compared to the United States of America market.
Price based on expected Growth
Does
NextGen Healthcare's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | 116.54x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 13 Analysts |
28.1%per year |
| United States of America Healthcare Services Industry PEG Ratio | Median Figure of 13 Publicly-Listed Healthcare Services Companies | 2.79x |
| United States of America Market PEG Ratio | Median Figure of 2,109 Publicly-Listed Companies | 1.55x |
*Line of best fit is calculated by linear regression .
| Calculation | Outcome | |
|---|---|---|
| PEG Ratio | = PE Ratio ÷ Net Income Annual Growth Rate = 116.54x ÷ 28.1% |
4.14x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- NextGen Healthcare is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on
NextGen Healthcare's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2018-12-31) in USD | $5.65 |
| NasdaqGS:NXGN Share Price * | NasdaqGS (2019-04-23) in USD | $17.28 |
| United States of America Healthcare Services Industry PB Ratio | Median Figure of 35 Publicly-Listed Healthcare Services Companies | 4.15x |
| United States of America Market PB Ratio | Median Figure of 5,185 Publicly-Listed Companies | 1.92x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = NasdaqGS:NXGN Share Price ÷ Book Value per Share (both in USD) = 17.28 ÷ 5.65 |
3.06x |
* Primary Listing of NextGen Healthcare.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- NextGen Healthcare is good value based on assets compared to the US Healthcare Services industry average.
Value checks
We assess NextGen Healthcare's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check) NextGen Healthcare has a total score of 1/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
NXGN Future Performance
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- NextGen Healthcare's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Growth vs Market Checks
- NextGen Healthcare's earnings growth is expected to exceed the United States of America market average.
- NextGen Healthcare's revenue growth is expected to exceed the United States of America market average.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| NasdaqGS:NXGN Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 13 Analysts | 28.1% |
| NasdaqGS:NXGN Future Revenue Growth Rate | Line of Best Fit* through Consensus Estimate Revenue of 13 Analysts | 7.7% |
| United States of America Healthcare Services Industry Earnings Growth Rate | Market Cap Weighted Average | 22.8% |
| United States of America Healthcare Services Industry Revenue Growth Rate | Market Cap Weighted Average | 11.6% |
| United States of America Market Earnings Growth Rate | Market Cap Weighted Average | 13.5% |
| United States of America Market Revenue Growth Rate | Market Cap Weighted Average | 7.1% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (3 months ago) | See Below |
| Future Estimates | Average of up to 13 Analyst Estimates (S&P Global) | See Below |
| Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * | Avg. No. Analysts |
|---|---|---|---|---|
| 2024-03-31 | 822 | 1 | ||
| 2023-03-31 | 747 | 1 | ||
| 2022-03-31 | 652 | 2 | ||
| 2021-03-31 | 591 | 83 | 32 | 8 |
| 2020-03-31 | 555 | 81 | 23 | 13 |
| 2019-03-31 | 527 | 52 | 20 | 12 |
| Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2018-12-31 | 530 | 55 | 10 |
| 2018-09-30 | 531 | 53 | 6 |
| 2018-06-30 | 533 | 66 | 1 |
| 2018-03-31 | 531 | 77 | 2 |
| 2017-12-31 | 528 | 84 | 18 |
| 2017-09-30 | 524 | 92 | 27 |
| 2017-06-30 | 518 | 111 | 23 |
| 2017-03-31 | 510 | 111 | 18 |
| 2016-12-31 | 505 | 95 | -2 |
| 2016-09-30 | 494 | 83 | -6 |
| 2016-06-30 | 493 | 50 | -1 |
| 2016-03-31 | 492 | 41 | 6 |
*GAAP earnings excluding extraordinary items.
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (3 months ago) | See Below |
| Future Estimates | Average of up to 13 Analyst Estimates (S&P Global) | See Below |
All data from NextGen Healthcare Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in USD Millions) | EPS * | EPS High Estimate | EPS Low Estimate | Avg. No. Analysts |
|---|---|---|---|---|
| 2024-03-31 | ||||
| 2023-03-31 | ||||
| 2022-03-31 | ||||
| 2021-03-31 | 0.47 | 0.56 | 0.34 | 5.00 |
| 2020-03-31 | 0.35 | 0.41 | 0.28 | 10.00 |
| 2019-03-31 | 0.32 | 0.35 | 0.30 | 9.00 |
| Date (Data in USD Millions) | EPS * |
|---|---|
| 2018-12-31 | 0.15 |
| 2018-09-30 | 0.10 |
| 2018-06-30 | 0.02 |
| 2018-03-31 | 0.04 |
| 2017-12-31 | 0.28 |
| 2017-09-30 | 0.43 |
| 2017-06-30 | 0.37 |
| 2017-03-31 | 0.30 |
| 2016-12-31 | -0.04 |
| 2016-09-30 | -0.09 |
| 2016-06-30 | -0.02 |
| 2016-03-31 | 0.09 |
*GAAP earnings excluding extraordinary items.
Future performance checks
We assess NextGen Healthcare's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
NextGen Healthcare has a total score of 4/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
NXGN Past Performance
How has NextGen Healthcare performed over the past 5 years?
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- NextGen Healthcare's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.
- NextGen Healthcare's 1-year earnings growth is negative, it can't be compared to the 5-year average.
- NextGen Healthcare's 1-year earnings growth is negative, it can't be compared to the US Healthcare Services industry average.
Earnings and Revenue History
All data from NextGen Healthcare Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in USD Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2018-12-31 | 530.16 | 9.52 | 172.58 | 82.28 |
| 2018-09-30 | 531.01 | 6.24 | 174.84 | 82.24 |
| 2018-06-30 | 533.30 | 1.17 | 173.39 | 82.80 |
| 2018-03-31 | 531.02 | 2.42 | 174.23 | 81.26 |
| 2017-12-31 | 527.63 | 17.88 | 169.38 | 82.27 |
| 2017-09-30 | 523.78 | 26.83 | 165.36 | 81.34 |
| 2017-06-30 | 518.34 | 22.78 | 161.77 | 80.11 |
| 2017-03-31 | 509.62 | 18.24 | 159.38 | 78.34 |
| 2016-12-31 | 505.15 | -2.50 | 158.39 | 72.31 |
| 2016-09-30 | 494.32 | -5.68 | 157.86 | 67.11 |
| 2016-06-30 | 492.52 | -1.35 | 157.45 | 66.80 |
| 2016-03-31 | 492.48 | 5.66 | 155.90 | 65.66 |
| 2015-12-31 | 492.95 | 32.72 | 155.64 | 67.22 |
| 2015-09-30 | 499.35 | 32.10 | 157.57 | 71.17 |
| 2015-06-30 | 494.50 | 28.53 | 158.88 | 70.09 |
| 2015-03-31 | 490.23 | 27.33 | 156.24 | 69.24 |
| 2014-12-31 | 477.04 | 21.79 | 154.04 | 66.72 |
| 2014-09-30 | 462.47 | 2.53 | 149.86 | 61.43 |
| 2014-06-30 | 453.03 | 7.90 | 150.29 | 52.15 |
| 2014-03-31 | 444.67 | 15.68 | 149.21 | 41.52 |
| 2013-12-31 | 440.76 | 6.39 | 147.05 | 34.64 |
| 2013-09-30 | 446.42 | 34.60 | 145.80 | 29.25 |
| 2013-06-30 | 451.46 | 40.17 | 144.92 | 27.90 |
| 2013-03-31 | 460.23 | 42.72 | 148.35 | 30.87 |
| 2012-12-31 | 457.93 | 61.89 | 144.24 | 31.54 |
| 2012-09-30 | 456.18 | 67.37 | 141.80 | 32.03 |
| 2012-06-30 | 447.69 | 72.17 | 136.14 | 33.12 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- NextGen Healthcare has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- NextGen Healthcare used its assets less efficiently than the US Healthcare Services industry average last year based on Return on Assets.
- NextGen Healthcare's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
Past performance checks
We assess NextGen Healthcare's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
NextGen Healthcare has a total score of 0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
NXGN Health
How is NextGen Healthcare's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up NextGen Healthcare's finances.
The net worth of a company is the difference between its assets and liabilities.
- NextGen Healthcare is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- NextGen Healthcare's cash and other short term assets cover its long term commitments.
Balance sheet
Assets
Liabilities and shares
- Low level of unsold assets.
- Debt is covered by short term assets, assets are 5.6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from NextGen Healthcare Company Filings, last reported 3 months ago.
| Date (Data in USD Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2018-12-31 | 365.37 | 28.13 | 30.05 |
| 2018-09-30 | 355.43 | 43.30 | 32.39 |
| 2018-06-30 | 336.89 | 45.46 | 26.54 |
| 2018-03-31 | 323.41 | 37.00 | 28.85 |
| 2017-12-31 | 330.74 | 39.00 | 23.36 |
| 2017-09-30 | 325.50 | 55.00 | 26.55 |
| 2017-06-30 | 314.19 | 45.00 | 23.34 |
| 2017-03-31 | 305.04 | 15.00 | 37.67 |
| 2016-12-31 | 297.75 | 25.00 | 23.99 |
| 2016-09-30 | 285.47 | 48.00 | 26.25 |
| 2016-06-30 | 270.13 | 88.00 | 26.35 |
| 2016-03-31 | 269.38 | 105.00 | 36.47 |
| 2015-12-31 | 284.58 | 0.00 | 104.81 |
| 2015-09-30 | 287.50 | 0.00 | 110.78 |
| 2015-06-30 | 279.95 | 0.00 | 116.80 |
| 2015-03-31 | 283.54 | 0.00 | 130.59 |
| 2014-12-31 | 282.50 | 0.00 | 124.82 |
| 2014-09-30 | 285.38 | 0.00 | 123.52 |
| 2014-06-30 | 290.54 | 0.00 | 116.44 |
| 2014-03-31 | 295.09 | 0.00 | 113.80 |
| 2013-12-31 | 299.74 | 0.00 | 93.99 |
| 2013-09-30 | 320.50 | 0.00 | 84.31 |
| 2013-06-30 | 310.10 | 0.00 | 130.03 |
| 2013-03-31 | 307.05 | 0.00 | 118.01 |
| 2012-12-31 | 321.09 | 0.00 | 106.69 |
| 2012-09-30 | 312.31 | 0.00 | 122.03 |
| 2012-06-30 | 306.56 | 0.00 | 134.90 |
- NextGen Healthcare's level of debt (7.7%) compared to net worth is satisfactory (less than 40%).
- The level of debt compared to net worth has increased over the past 5 years (0% vs 7.7% today).
- Debt is well covered by operating cash flow (194.1%, greater than 20% of total debt).
- Interest payments on debt are well covered by earnings (EBIT is 7.5x coverage).
Financial health checks
We assess NextGen Healthcare's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) NextGen Healthcare has a total score of 5/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
NXGN Dividends
What is NextGen Healthcare's current dividend yield, its reliability and sustainability?
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
$2,000 of
NextGen Healthcare
shares you are expected to receive
$0
in your first year as a dividend.
Dividend Amount
- Unable to evaluate NextGen Healthcare's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate NextGen Healthcare's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 13 Analyst Estimates (S&P Global) | See Below |
| Global Healthcare Services Industry Average Dividend Yield | Market Cap Weighted Average of 15 Stocks | 1.3% |
| United States of America Market Average Dividend Yield | Market Cap Weighted Average of 2008 Stocks | 2.4% |
| United States of America Minimum Threshold Dividend Yield | 10th Percentile | 0.8% |
| United States of America Bottom 25% Dividend Yield | 25th Percentile | 1.4% |
| United States of America Top 25% Dividend Yield | 75th Percentile | 3.6% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
| Date (Data in $) | Dividend per Share (annual) | Avg. No. Analysts |
|---|---|---|
| 2024-03-31 | ||
| 2023-03-31 | ||
| 2022-03-31 | ||
| 2021-03-31 | 0.00 | 2.00 |
| 2020-03-31 | 0.00 | 2.00 |
| 2019-03-31 | 0.00 | 2.00 |
| Date (Data in $) | Dividend per share (annual) | Avg. Yield (%) |
|---|---|---|
| 2017-10-26 | 0.000 | 0.000 |
| 2017-08-01 | 0.000 | 0.000 |
| 2017-05-19 | 0.000 | 0.000 |
| 2017-01-26 | 0.000 | 0.000 |
| 2017-01-25 | 0.000 | 0.000 |
| 2016-10-27 | 0.000 | 0.000 |
| 2016-07-29 | 0.000 | 0.000 |
| 2016-07-28 | 0.000 | 0.000 |
| 2016-05-25 | 0.000 | 0.000 |
| 2016-05-19 | 0.000 | 0.000 |
| 2016-01-29 | 0.700 | 4.835 |
| 2016-01-28 | 0.700 | 4.821 |
| 2015-10-23 | 0.700 | 4.491 |
| 2015-10-22 | 0.700 | 5.047 |
| 2015-07-23 | 0.700 | 5.455 |
| 2015-05-26 | 0.700 | 4.285 |
| 2015-05-21 | 0.700 | 4.195 |
| 2014-10-23 | 0.700 | 4.436 |
| 2014-07-24 | 0.700 | 4.764 |
| 2014-05-29 | 0.700 | 4.433 |
| 2013-10-24 | 0.700 | 3.806 |
| 2013-07-29 | 0.700 | 3.196 |
| 2013-05-28 | 0.700 | 3.643 |
| 2013-05-23 | 0.700 | 3.836 |
| 2012-10-26 | 0.700 | 3.855 |
| 2012-07-27 | 0.700 | 3.878 |
| 2012-05-30 | 0.700 | 2.713 |
| 2012-01-26 | 0.700 | 1.803 |
| 2011-10-27 | 0.700 | 1.888 |
| 2011-07-28 | 0.700 | 1.584 |
| 2011-05-26 | 0.700 | 1.646 |
| 2011-01-28 | 0.700 | 1.678 |
| 2010-10-29 | 0.600 | 1.770 |
| 2010-07-30 | 0.600 | 1.984 |
| 2010-05-28 | 0.600 | 2.098 |
| 2010-02-02 | 0.600 | 2.000 |
| 2009-11-02 | 0.600 | 1.949 |
| 2009-10-30 | 0.600 | 1.973 |
| 2009-08-03 | 0.600 | 2.076 |
| 2009-07-30 | 0.600 | 2.187 |
| 2009-04-24 | 0.600 | 2.245 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Unable to perform a dividend volatility check as NextGen Healthcare has not reported any payouts.
- Unable to verify if NextGen Healthcare's dividend has been increasing as the company has not reported any payouts.
Income/ dividend checks
We assess NextGen Healthcare's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can NextGen Healthcare afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) NextGen Healthcare has a total score of 0/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
NXGN Management
CEO
| COMPENSATION | $3,752,839 |
| AGE | 51 |
| TENURE AS CEO | 3.8 years |
CEO Bio
Mr. John R. Frantz, also known as Rusty, serves as President and Chief Executive Officer of NextGen Healthcare information Systems, LLC. Mr. Frantz has been the President and Chief Executive Officer of NextGen Healthcare, Inc. (formerly, Quality Systems, Inc.) since July 1, 2015. Previously, he served as Senior Vice President and General Manager of Global Dispensing Division, of CareFusion Corp. (“CareFusion”) from 2011 to March 2015, when CareFusion was acquired by Becton, Dickinson and Company. He also served as Vice President of Research and Development, for CareFusion’s Pyxis business unit from 2010 to 2011, as General Manager of CareFusion’s Pyxis Perioperative Solutions from 2008 to 2010 and as CareFusion’s Vice President, Marketing, Supply Technologies from 2007 to 2008. Prior to his employment with CareFusion, Mr. Frantz served as Vice President of Marketing at Cerfidia Solutions, Vice President, Marketing and Product Management at Amphire Solutions, Co-Founder and Vice President of Engineering, at OutPurchase, and held various other management positions in the health care industry. Mr. Frantz holds a Master of Science degree in Engineering from Stanford University and a Bachelor of Science degree in engineering from the Maine Maritime Academy.
CEO Compensation
- Rusty's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
- Rusty's remuneration is higher than average for companies of similar size in United States of America.
Management Team Tenure
Average tenure and age of the NextGen Healthcare management team in years:
- The tenure for the NextGen Healthcare management team is about average.
Management Team
Rusty Frantz
President
$4M
51
3.8 yrs
Jamie Arnold
Executive VP
$2M
62
3.1 yrs
David Metcalfe
Executive VP & Chief Technology Officer
$1M
55
3.2 yrs
Jeff Linton
Executive VP
$1M
55
1.3 yrs
Donna Greene
Senior Vice President of Human Resources
John Beck
Chief Solutions Officer & Executive VP
2.7 yrs
Betty Rabinowitz
Chief Medical Officer
1 yrs
Asher Dewhurst
Investor Relations
Board of Directors Tenure
Average tenure and age of the NextGen Healthcare board of directors in years:
- The tenure for the NextGen Healthcare board of directors is about average.
Board of Directors
Jeff Margolis
Independent Chairman
$327K
55
3.4 yrs
Rusty Frantz
President
$4M
51
3.7 yrs
Craig Barbarosh
Vice Chairman
$361K
50
3.4 yrs
George Bristol
Independent Director
$283K
69
10.6 yrs
Morris Panner
Independent Director
$261K
55
6.3 yrs
Lance Rosenzweig
Independent Director
$245K
55
6.9 yrs
Jim Malone
Independent Director
$265K
69
6.3 yrs
Sheldon Razin
Chairman Emeritus
$315K
80
45.3 yrs
Julie Klapstein
Independent Director
$206K
63
1.7 yrs
Who owns this company?
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price ($) | Value ($) | |
|---|---|---|---|---|---|---|---|---|---|---|
Management checks
We assess NextGen Healthcare's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) NextGen Healthcare has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
NXGN News
Simply Wall St News
Should You Worry About NextGen Healthcare, Inc.’s (NASDAQ:NXGN) ROCE?
To be precise, we'll consider its Return On Capital Employed (ROCE), as that will inform our view of the quality of the business. … Understanding Return On Capital Employed (ROCE). … How Do You Calculate Return On Capital Employed
Simply Wall St - – Full articleWhat Does NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Share Price Indicate?
NextGen Healthcare, Inc. … As a stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock? … Today I will analyse the most recent data on NextGen Healthcare’s outlook and valuation to see if the opportunity still exists
Simply Wall St - – Full articleIf You Had Bought NextGen Healthcare Stock A Year Ago, You Could Pocket A 42% Gain Today
(NASDAQ:NXGN) share price is 42% higher than it was a year ago, much better than the market return of around 2.6% (not including dividends) in the same period. … In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. … One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.
Simply Wall St - – Full articleOur Take On NextGen Healthcare, Inc.'s (NASDAQ:NXGN) CEO Salary
This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. … View our latest analysis for NextGen Healthcare? … How Does Rusty Frantz's Compensation Compare With Similar Sized Companies?
Simply Wall St - – Full articleNextGen Healthcare, Inc. (NASDAQ:NXGN): What Does Its Beta Value Mean For Your Portfolio?
Some investors use beta as a measure of how much a certain stock is impacted by market risk (volatility). … A stock with a beta below one is either less volatile than the market, or more volatile but not corellated with the overall market. … In comparison a stock with a beta of over one tends to be move in a similar direction to the market in the long term, but with greater changes in price.
Simply Wall St - – Full articleWhat Is NextGen Healthcare Inc's (NASDAQ:NXGN) Share Price Doing?
NextGen Healthcare Inc (NASDAQ:NXGN), which is in the healthcare services business, and is based in United States,. … A question to answer is whether NextGen Healthcare's current trading price of $15.13 reflective of the actual value of the? … Let’s take a look at NextGen Healthcare’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change
Simply Wall St - – Full articleNextGen Healthcare Inc (NASDAQ:NXGN): Why Return On Capital Employed Is Important
and want to better understand how you can grow your money by investing in NextGen Healthcare Inc (NASDAQ:NXGN). … Your equity share is granted in return for the capital provided to the business to operate, and in order for an investment to be successful the business has to create earnings from the funds that make up this capital. … Thus, to understand how your money can grow by investing in NextGen Healthcare, you need to look at what the company returns to owners for the use of their capital, which can be done in many ways but today we will use return on capital employed (ROCE)
Simply Wall St - – Full articleNXGN Company Info
Description
NextGen Healthcare, Inc. provides software, services, and analytics solutions to medical and dental group practices in the United States. The company’s principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools. Its products also comprise NextGen Enterprise PM, a practice management (PM) solution; and NextGen Office, a cloud-based electronic health record and PM solution. In addition, the company offers automation and workflow solutions, including NextGen Mobile Health Solutions, NextGen Electronic Healthcare Transactions, NextGen Pre-Service Clearance, and NextGen Patient Payment solutions. Further, it provides analytics, population health, and patient engagement solutions, such as NextGen Population Health Informed Analytics, NextGen Population Health Patient Care Coordination, NextGen Population Health Performance Management, and NextGen Patient Portal solutions. Additionally, the company offers NextGen Connected Health and NextGen Share interoperability solutions. It also provides professional services, including training, project management, functional and detailed specification preparation, configuration, testing, installation, support, and client services. It serves physician hospital and management service organizations, independent physician associations, accountable care organizations, ambulatory care centers, and community health centers through a sales force and reseller channel. NextGen Healthcare, Inc. has a strategic partnership with OTTO Health LLC. The company was formerly known as Quality Systems, Inc. and changed its name to NextGen Healthcare, Inc. in September 2018. NextGen Healthcare, Inc. was founded in 1974 and is headquartered in Irvine, California.
Details
| Name: | NextGen Healthcare, Inc. |
| NXGN | |
| Exchange: | NasdaqGS |
| Founded: | 1974 |
| $1,117,962,656 | |
| 64,696,913 | |
| Website: | http://www.nextgen.com |
| Address: |
NextGen Healthcare, Inc. 18111 Von Karman Avenue, Suite 800, Irvine, California, 92612, United States |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| NasdaqGS | NXGN | Common Stock | Nasdaq Global Select | US | USD | 01. Dec 1982 | |
| DB | QY1 | Common Stock | Deutsche Boerse AG | DE | EUR | 01. Dec 1982 |
Number of employees
Current staff
Industry
| Health Care Technology | |
| Healthcare |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/04/23 23:43 |
| End of day share price update: | 2019/04/23 00:00 |
| Last estimates confirmation: | 2019/02/08 |
| Last earnings filing: | 2019/01/24 |
| Last earnings reported: | 2018/12/31 |
| Last annual earnings reported: | 2018/03/31 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
